Cargando…
EMAP II Expression Is Increased on Peripheral Blood Cells from Non-Hodgkin Lymphoma
Tumor immune evasion is a lineament of cancer. Endothelial monocyte activating polypeptide-II (EMAP II) has been assumed to impact tumor immune escape significantly. EMAP II was first reported in the murine methylcholanthrene A-induced fibrosarcoma supernatant and identified as a tumor-derived cytok...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484964/ https://www.ncbi.nlm.nih.gov/pubmed/36132984 http://dx.doi.org/10.1155/2022/7219207 |